RU2006125309A - METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION - Google Patents

METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION Download PDF

Info

Publication number
RU2006125309A
RU2006125309A RU2006125309/14A RU2006125309A RU2006125309A RU 2006125309 A RU2006125309 A RU 2006125309A RU 2006125309/14 A RU2006125309/14 A RU 2006125309/14A RU 2006125309 A RU2006125309 A RU 2006125309A RU 2006125309 A RU2006125309 A RU 2006125309A
Authority
RU
Russia
Prior art keywords
endothelial dysfunction
correction
enalapril
dose
intraperitoneally
Prior art date
Application number
RU2006125309/14A
Other languages
Russian (ru)
Inventor
Михаил Владимирович Покровский (RU)
Михаил Владимирович Покровский
Элгар Андреевич Парфенов (RU)
Элгар Андреевич Парфенов
Тать на Григорьевна Покровска (RU)
Татьяна Григорьевна Покровская
Владимир Исхакович Кочкаров (RU)
Владимир Исхакович Кочкаров
Елена Борисовна Артюшкова (RU)
Елена Борисовна Артюшкова
Евгений Николаевич Пашин (RU)
Евгений Николаевич Пашин
Сергей Алексеевич Литвинов (RU)
Сергей Алексеевич Литвинов
Людмила Михайловна Даниленко (RU)
Людмила Михайловна Даниленко
ков Александр Игоревич Ма (RU)
Александр Игоревич Маяков
Ирина Александровна Татаренкова (RU)
Ирина Александровна Татаренкова
Алексей Сергеевич Долженков (RU)
Алексей Сергеевич Долженков
Любовь Ивановна Тихова (RU)
Любовь Ивановна Тихова
Original Assignee
Элгар Андреевич Парфенов (RU)
Элгар Андреевич Парфенов
Людмила Михайловна Даниленко (RU)
Людмила Михайловна Даниленко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Элгар Андреевич Парфенов (RU), Элгар Андреевич Парфенов, Людмила Михайловна Даниленко (RU), Людмила Михайловна Даниленко filed Critical Элгар Андреевич Парфенов (RU)
Priority to RU2006125309/14A priority Critical patent/RU2006125309A/en
Publication of RU2006125309A publication Critical patent/RU2006125309A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ коррекции эндотелиальной дисфункции, включающий использование эналаприла, относящегося к ингибиторам АПФ, отличающийся тем, что в эксперименте лабораторному животному с эндотелиальной дисфункцией на фоне ее моделирования вводят внутрижелудочно эналаприл в дозе 0,5 мг/кг и внутрибрюшинно πQ510 в дозе 30 мг/кг однократно в сутки.A method for correcting endothelial dysfunction, including the use of enalapril, an ACE inhibitor, characterized in that, in an experiment, a laboratory animal with endothelial dysfunction is administered intragastrically enalapril at a dose of 0.5 mg / kg and intraperitoneally πQ510 at a dose of 30 mg / kg once per day.
RU2006125309/14A 2006-07-14 2006-07-14 METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION RU2006125309A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006125309/14A RU2006125309A (en) 2006-07-14 2006-07-14 METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006125309/14A RU2006125309A (en) 2006-07-14 2006-07-14 METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION

Publications (1)

Publication Number Publication Date
RU2006125309A true RU2006125309A (en) 2008-01-20

Family

ID=39108453

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006125309/14A RU2006125309A (en) 2006-07-14 2006-07-14 METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION

Country Status (1)

Country Link
RU (1) RU2006125309A (en)

Similar Documents

Publication Publication Date Title
IL259851A (en) Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP1848432A4 (en) Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
EA201200890A1 (en) Combined HCV therapy
BRPI0812738A2 (en) COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHOD FOR THE TREATMENT OF A VIRAL INFECTION IN A HUMAN
EA201170958A1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODYPINE AND LOZARTAN AND METHOD FOR ITS PREPARATION
EA201100795A1 (en) PHARMACEUTICAL COMPOSITION OF EFFICIENT HSG INHIBITOR FOR ORAL ADMINISTRATION
EA200970933A1 (en) METHODS OF TREATMENT OR PREVENTION OF VOMITING THROUGH AGENTS STRENGTHENING THE GROWTH HORMONE SECRETION
EA200801619A1 (en) METHOD OF IMPROVING PHARMACOKINETICS INHIBITORS INHIBITORS HIV (OPTIONS), SET AND PHARMACEUTICAL COMPOSITION (OPTIONS)
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
EP3276004A3 (en) Methods for treating chronic kidney disease
IL193252A0 (en) N-hydroxyacrylamide compounds
EA201000039A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT
MX2007004020A (en) Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure.
EP1902715A3 (en) Use of paliperidone for the treatment of psychiatric patients with reduced hepatic function
RU2006146326A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS C
PL1848419T3 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
RU2005140967A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF LOZARTAN AND RESVERATROL IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY
DE602007011316D1 (en) PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC, ANTIDEPRESSIVE OR ANTIEPILEPTIC EFFECT WITH REDUCED SIDE EFFECTS
RU2005140968A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF LOZARTAN AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY
RU2006125309A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION
RU2007103667A (en) METHOD FOR TREATING PSORIASIS
RU2007104920A (en) METHOD FOR REDUCING TOXIC LIVER INJURY
RU2005140971A (en) METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF AMLODIPINE AND RESVERATROL IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY
RU2017139933A (en) METHOD OF CORRECTION OF ADMA-LIKE PRE-LAMPSI